Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Beam Therapeutics Inc Logo

ARKK Holdings of Beam Therapeutics (BEAM) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
July 19, 2021BUY13350.0005%ARKK
July 16, 2021BUY51510.0021%ARKK
May 20, 2021BUY300000.0108%ARKK
May 18, 2021BUY2000.0001%ARKK
May 13, 2021BUY621690.0221%ARKK

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$84.37
⚖️Weighting🧢Market Cap
1.78%$5.52b
🏋🏿‍♂️Weight Rank In ARKK🧮Price to Sales
21230166.64
🏋️‍♀️Weight Rank Across All Funds🐻Short Percent
2411.45
🎫Ark Ownership Percent🌏Country
6.99%🇺🇸United States
Description
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Website
beamtx.com

Research Notes and Commentary for BEAM